Cantor Fitzgerald’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,642
Closed -$327K 601
2023
Q3
$327K Hold
1,642
0.01% 385
2023
Q2
$469K Hold
1,642
0.01% 379
2023
Q1
$356K Sell
1,642
-46
-3% -$8.96K 0.01% 467
2022
Q4
$347K Buy
1,688
+12
+0.7% +$3.03K 0.01% 506
2022
Q3
$466K Sell
1,676
-12
-0.7% -$3.05K 0.01% 520
2022
Q2
$323K Buy
+1,688
New +$298K 0.01% 596

Other funds holding SWAV

Cantor Fitzgerald's SWAV Position: Q4 2023 in Review

Cantor Fitzgerald sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 1,642 shares — an estimated $327K sold.

Cantor Fitzgerald first reported a position in SWAV in Q2 2022 and held it in 6 quarters. The position peaked at $469K in Q2 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Cantor Fitzgerald reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 1,642 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $327K.
  • Cantor Fitzgerald first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Cantor Fitzgerald's Shockwave Medical, Inc. Common Stock position peaked at $469K in Q2 2023.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.